CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
3.090
+0.260 (9.19%)
At close: Sep 26, 2025, 4:00 PM EDT
2.910
-0.180 (-5.83%)
After-hours: Sep 26, 2025, 7:40 PM EDT
CollPlant Biotechnologies Employees
CollPlant Biotechnologies had 57 employees as of December 31, 2024. The number of employees decreased by 18 or -24.00% compared to the previous year.
Employees
57
Change (1Y)
-18
Growth (1Y)
-24.00%
Revenue / Employee
$42,140
Profits / Employee
-$228,123
Market Cap
39.93M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CLGN News
- 12 days ago - CollPlant Expands the Distribution of its VergenixSTR Product in Europe - PRNewsWire
- 25 days ago - CollPlant to Present at the 2025 International Conference on Biofabrication - PRNewsWire
- 4 weeks ago - CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference - PRNewsWire
- 5 weeks ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 7 weeks ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS - PRNewsWire
- 2 months ago - CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations - PRNewsWire
- 3 months ago - COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES - PRNewsWire
- 4 months ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS - PRNewsWire